GATA3 is thought to decrease the onset and intensity of MS by directing the differentiation of Th cells toward Th2 and regulatory T cells (Tregs) while suppressing the differentiation of Th1 and Th17 cells. This evidence concerns the gene GATA3 and myeloid sarcoma.